BEM-99546-54680
2 vaccinations
3 coded responses
21 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 347 / FL
- Registered
- 2021-11-13
- Relationship
- Child or adolescent in my care
- Guardian
- SGK-23238-96904
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-13
Registered in v-safe
-
2021-11-13
Dose 1 — Pfizer-BioNTech
- 2021-11-13
-
2021-11-14
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain, Itching · NoneAdult check-in
- 2021-11-15
-
2021-11-17
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Fair · Site: Pain, Itching · Headache, Nausea, Abdominal pain · Be unable to work or attend schoolAdult check-in
-
2021-11-18
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Fair · Site: Pain, Itching · Fatigue or tiredness, Abdominal painAdult check-in
- 2021-11-20
- 2021-11-28
-
2021-12-04
Dose 2 — Pfizer-BioNTech
- 2021-12-04
- 2021-12-05
- 2021-12-06
- 2021-12-09
- 2021-12-10
- 2021-12-11
-
2021-12-18
Survey response — day 14, dose 2, dependentMedDRA: Nasal congestion — Feeling: GoodFree text: Stuffed noseMedDRA releases: 2024-11 · check-in free text available
- 2021-12-25
- 2022-01-01
- 2022-01-08
- 2022-01-17
- 2022-03-05
-
2022-06-04
Survey response — 6 months, dose 2, dependentMedDRA: Nasal congestion, Oropharyngeal pain — Feeling: GoodFree text: Mild sore throat and stuffy nose x 48 hours.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-04
Survey response — 12 months, dose 2, dependentMedDRA: Gastrointestinal viral infection — Feeling: Good · Be unable to work or attend schoolFree text: Short viral GI diseaseMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-13 | Pfizer-BioNTech | No |
| 2 | 2021-12-04 | Pfizer-BioNTech | No |
Free text
Release 10 — day 14, dose 2, dependent
Symptoms: Stuffed nose
Release 11 — 6 months, dose 2, dependent
Symptoms: Mild sore throat and stuffy nose x 48 hours.
Release 12 — 12 months, dose 2, dependent
Symptoms: Short viral GI disease
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gastrointestinal viral infection | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release